Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Complete Donald Trump Stock Impact Guide
November 9, 2016 12:03 PM ESTDonald Trump's victory not only shocked the world but shocked the market. Below are all the sectors and stocks being impacted by his victory:
Biotech (Positive): Trump is viewed as less onerous than Clinton on drug pricing.
Gilead Sciences (NASDAQ: GILD) +4.5%Celgene (NASDAQ: CELG) +8.5%XBI (NYSE: XBI) is up 7%IBB (NYSE: IBB) is up 6.6%Alexion Pharmaceuticals (NASDAQ: ALXN)... MoreValeant Pharma (VRX) Shares See Early Bounce Higher
November 9, 2016 8:56 AM ESTValeant Pharma (NYSE: VRX) shares are ticking higher early following a 22 percent drop on Monday amid weak Q3 results and cut outlook. The stock is up well over 2 percent ahead of the opening bell, going against broader market pressure.
... More